Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2024 Earnings Call Transcript

David Baron: Thank you.

Operator: Thank you. And there were no other questions from the lines at this time. I would now like to hand the call back to Dr. Morris for closing remarks.

Ronnie Morris: Thank you for joining us for our quarterly earnings call. A lot of good things happening at Champions Oncology. We’re very excited about the drug discovery effort that we have. We’re very excited about some of the new assays that we’ve been rolling out, especially our ex vivo assay. We continue to be excited about our in vivo work that we do. And clearly, the biomarker that we perform for biopharma. So in all areas, I think we continue to have an excellent reputation in the marketplace for doing good, high quality work. We are scientifically inclined, collaborative. And I think those are all the recipes for continued success. So we look forward to discussing those with you on our next quarterly call. And thank you, everybody, and have a good afternoon. Bye.

Operator: Thank you. This does conclude today’s conference. You may disconnect your lines at this time. Thank you for your participation.